{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ngyaALfwWc\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/20100\/\">2003 \u5e74 2 \u6708 28 \u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/20100\/embed\/#?secret=ngyaALfwWc\" width=\"600\" height=\"338\" title=\"\u201c\u300c2003\u5e742\u670828\u65e5\u306e\u52d5\u7269\u885b\u751f\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8\u300d\u2014 Brakke Consulting\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\" data-secret=\"ngyaALfwWc\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 28, 2003 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES &gt;&nbsp; Alpharma reported that sales of its animal health division in the 4th quarter 2002 were $88.3 million, an increase of 34% over the fourth quarter 2001.&nbsp; Management noted that the animal health division had good results but that 2001 was an unusually low quarter.&nbsp; For the full year, animal health sales declined 4% to $322 million.&nbsp; (company website)&nbsp; &gt;&nbsp; Nestle reported that year-end 2002 sales of its petcare division were CHF 10,719 million ($7,732 million), an increase of 72% over year-end 2001.&nbsp; Earnings before interest, taxes and adjustments were CHF 1,418 million ($1,023 million), an increase of 213% over 2001.&nbsp; Nestl\u00e9 Purina PetCare USA managed to grow both sales and market share while undergoing a very successful integration process. Nestl\u00e9 Purina PetCare Europe focused on improving margins through product rationalization. Nestle began consolidating sales of Ralston Purina on January 1, 2002.&nbsp; (company website) &gt;&nbsp; AVANT Immunotherapeutics, Inc. reported financial results for the year ended December 31, 2002.&nbsp; For the year ended December 31, 2002, the Company reported a net loss of $13.8 million compared to a net loss of $22.8 million for fiscal 2001. The full year results for 2002 reflect an increase in revenue combined with aView Full Post;"}